Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

3.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
4.
5.

The CD4 T cell response to respiratory syncytial virus infection.

Christiaansen AF, Knudson CJ, Weiss KA, Varga SM.

Immunol Res. 2014 Aug;59(1-3):109-17. doi: 10.1007/s12026-014-8540-1. Review.

PMID:
24838148
6.

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.

Muralidharan A, Li C, Wang L, Li X.

Expert Rev Vaccines. 2017 Apr;16(4):351-360. doi: 10.1080/14760584.2017.1260452. Epub 2016 Nov 21. Review.

PMID:
27841687
7.

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.

Acosta PL, Caballero MT, Polack FP.

Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95. doi: 10.1128/CVI.00609-15. Review.

8.

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Collins PL, Melero JA.

Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22. Review.

9.

Gene-based vaccine approaches for respiratory syncytial virus.

Loomis RJ, Johnson PR.

Curr Top Microbiol Immunol. 2013;372:307-24. doi: 10.1007/978-3-642-38919-1_15. Review.

PMID:
24362696
10.

Strategic priorities for respiratory syncytial virus (RSV) vaccine development.

Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS.

Vaccine. 2013 Apr 18;31 Suppl 2:B209-15. doi: 10.1016/j.vaccine.2012.11.106. Review.

11.

Respiratory syncytial virus vaccine development.

Murata Y.

Clin Lab Med. 2009 Dec;29(4):725-39. doi: 10.1016/j.cll.2009.07.004. Review.

12.

Modulation of the host immune response by respiratory syncytial virus proteins.

Schmidt ME, Varga SM.

J Microbiol. 2017 Mar;55(3):161-171. doi: 10.1007/s12275-017-7045-8. Epub 2017 Feb 28. Review.

PMID:
28243940

Supplemental Content

Support Center